Sionna Therapeutics Inc [SION] is -55.72% lower this YTD. Is it still time to buy?

Sionna Therapeutics Inc [NASDAQ: SION] traded at a high on Thursday, posting a 10.70 gain after which it closed the day’ session at $11.07.

The results of the trading session contributed to over 186207 shares changing hands. Over the past one week, the price volatility of Sionna Therapeutics Inc stands at 14.45% while the volatility over the past one month is 13.92%.

The market cap for SION stock reached $488.45 million, with 44.12 million shares outstanding and 27.05 million shares in the current float. Compared to the average trading volume of 253.18K shares, SION reached a trading volume of 186207 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Sionna Therapeutics Inc [SION]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SION shares is $38.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SION stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

TD Cowen have made an estimate for Sionna Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 04, 2025. While these analysts kept the previous recommendation, Stifel raised their target price to Buy. The new note on the price target was released on March 04, 2025, representing the official price target for Sionna Therapeutics Inc stock. Previously, the target price had yet another raise to $45, while Guggenheim analysts kept a Buy rating on SION stock.

How has SION stock performed recently?

Sionna Therapeutics Inc [SION] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 44.52.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SION stock in for the last two-week period is set at 45.27, with the RSI for the last a single of trading hit 54.83, and the three-weeks RSI is set at 39.10 for Sionna Therapeutics Inc [SION]. The present Moving Average recorded at 9.47 for the last single week of trading.

Sionna Therapeutics Inc [SION]: Deeper insight into the fundamentals

Sionna Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 14.49 and a Current Ratio set at 14.49.

Earnings analysis for Sionna Therapeutics Inc [SION]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SION. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sionna Therapeutics Inc go to 45.72%.

Insider trade positions for Sionna Therapeutics Inc [SION]

There are presently around $68.21%, or 73.51%% of SION stock, in the hands of institutional investors.